CHRISTINE ASHTON: Open Payments
NPI 1225308927 · DAWSONVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,294 in 106 payments from 15 companies in 2025. Trend: 2023 $2,304 · 2024 $3,576 · 2025 $3,294
Food & beverage: $3,020Education: $273
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $512 |
| Regeneron Healthcare Solutions, Inc. | 18 | $490 |
| GENZYME CORPORATION | 16 | $457 |
| Janssen Biotech, Inc. | 6 | $338 |
| Galderma Laboratories, L.P. | 7 | $313 |
| Arcutis Biotherapeutics, Inc. | 9 | $293 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $256 |
| MERZ NORTH AMERICA, INC. | 1 | $150 |
| Lilly USA, LLC | 5 | $122 |
| E.R. Squibb & Sons, L.L.C. | 4 | $94 |
Products named: DUPIXENT, TREMFYA, NEMLUVIO, Zoryve, SKYRIZI, BOTOX, RINVOQ, Xeomin.
Industry payments across GA — which companies pay providers there.
